Specialty & Oncology August 2020
Advances in the Management of Sickle Cell Disease
Three novel agents were recently approved to reduce the incidence of vaso-occlusive pain crises and/or anemia in sickle cell patients.
Guest Editorial: Assuming the Front Line of ADR Reporting
Pharmacists can contribute to the evolving understanding of the postmarketing surveillance that can lead to official FDA labeling updates and, perhaps, future medication-use recommendations.
Hemophilia Review
In recent years, a number of new drugs have been FDA-approved to treat this bleeding disorder, and recent trial data on gene therapy are promising.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.